Manali Kamdar

17PUBLICATIONS
171CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Applied statisticsLiquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 28, 2026
CAR T-cell therapy referral patterns and utilization for relapsed/refractory large B-cell lymphoma in the United States.

|Jul 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel for 3L+ FL: 3-year update from TRANSCEND FL.

|Jun 04, 2026
Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study.

|Apr 27, 2026
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

|Mar 23, 2026
From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma.

Manali Kamdar, Nancy L Bartlett

|Feb 26, 2026
Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

John Sharp, Paolo Strati, Subodh Bhatta

Pageof 3

Frequent Collaborators

6 joint publications

Jeremy S Abramson

4 joint publications

Yucai Wang

4 joint publications

Reem Karmali

4 joint publications

Natalie S Grover